Honz Pharmaceutical Co., Ltd. (SHE:300086)

Market Cap	2.78B -23.6%
Revenue (ttm)	450.28M -5.6%
Net Income	-232.20M
EPS	-0.51
Shares Out	455.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,079,473
Open	6.20
Previous Close	6.17
Day's Range	6.06 - 6.52
52-Week Range	5.46 - 15.19
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Honz Pharmaceutical

Honz Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pediatric medicines in China and internationally. It operates through Pharmaceutical Manufacturing and Sales; and Daily Necessities Manufacturing and Sales segments. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal, cough relief, anti-flu, antipyretic-analgesic, anti-infection, anti-fungal, endocrine, anti-allergy, antibacterial and antiviral, respiratory system, digesti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 540
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300086

Financial Performance

In 2025, Honz Pharmaceutical's revenue was 466.12 million, a decrease of -0.72% compared to the previous year's 469.53 million. Losses were -230.14 million, 6.82% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error